Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.
3.
5.
6.

Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.

Corren J, Nelson H, Greos LS, Bensch G, Goldstein M, Wu J, Wang S, Newman K.

Ann Allergy Asthma Immunol. 2001 Nov;87(5):405-11.

PMID:
11730183
7.

Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.

Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.

Ann Allergy Asthma Immunol. 2001 May;86(5):557-65.

PMID:
11379808
8.

A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.

Vondra V, Sladek K, Kotasová J, Terl M, Rossetti A, Cantini L.

Respir Med. 2002 Oct;96(10):784-9.

PMID:
12412977
11.

A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.

Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.

Ann Allergy Asthma Immunol. 2002 May;88(5):488-93.

PMID:
12027070
12.

Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.

Chopra N, Williams M, Rimmer M, Kahl L, Jenkins M; SMO30006 and SMO30007 International Study Teams..

Respir Med. 2005 Apr;99 Suppl A:S1-S10. Epub 2005 Jan 26.

14.

Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.

Ramsdell JW, Colice GL, Ekholm BP, Klinger NM.

Ann Allergy Asthma Immunol. 1998 Dec;81(6):593-9.

PMID:
9892032
15.

Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.

Ayres JG, Simmons JL, Stampone P.

Respir Med. 1999 Jan;93(1):27-32.

PMID:
10464845
16.

Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.

Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.

J Aerosol Med. 2002 Winter;15(4):407-14.

PMID:
12581507
17.

Safety of long-term treatment with HFA albuterol.

Ramsdell JW, Klinger NM, Ekholm BP, Colice GL.

Chest. 1999 Apr;115(4):945-51.

PMID:
10208190
18.

Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.

Boulet LP, Cartier A, Ernst P, Larivée P, Laviolette M.

Can Respir J. 2004 Mar;11(2):123-30.

PMID:
15045043
19.

Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group.

Baumgarten CR, Dorow P, Weber HH, Gebhardt R, Kettner J, Sykes AP.

Respir Med. 2000 Jun;94 Suppl B:S17-21.

PMID:
10919681
20.

Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.

Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Cooper KM, Porietis I, McEwen J.

Eur J Clin Pharmacol. 1995;48(6):473-7.

PMID:
8582466

Supplemental Content

Support Center